Study to Assess Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of Palovarotene Ophthalmic Solution in Healthy Adult Subjects
Clinical trial NCT04762355 · COMPLETED
Trial details
- NCT number
- NCT04762355
- Sponsor
- Clementia Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-30
- Primary completion
- 2019-01-03
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.